Preston Klassen

2013 - Orexigen Therapeutics

In 2013, Preston Klassen earned a total compensation of $1.6M as Executive Vice President, Global Product Development at Orexigen Therapeutics, a 29% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$214,600
Option Awards$1,049,874
Salary$370,000
Other$180
Total$1,634,654

Klassen received $1M in option awards, accounting for 64% of the total pay in 2013.

Klassen also received $214.6K in non-equity incentive plan, $370K in salary and $180 in other compensation.

Rankings

In 2013, Preston Klassen's compensation ranked 4,598th out of 12,286 executives tracked by ExecPay. In other words, Klassen earned more than 62.6% of executives.

ClassificationRankingPercentile
All
4,598
out of 12,286
63rd
Division
Manufacturing
1,572
out of 4,612
66th
Major group
Chemicals And Allied Products
454
out of 1,462
69th
Industry group
Drugs
316
out of 1,156
73rd
Industry
Pharmaceutical Preparations
255
out of 890
71st
Source: SEC filing on May 27, 2016.

Klassen's colleagues

We found four more compensation records of executives who worked with Preston Klassen at Orexigen Therapeutics in 2013.

2013

Michael Narachi

Orexigen Therapeutics

Chief Executive Officer

2013

Joseph Hagan

Orexigen Therapeutics

Former Chief Business and Financial Officer

2013

Heather Turner

Orexigen Therapeutics

General Counsel

2013

Mark Booth

Orexigen Therapeutics

Chief Commercial Officer outgoing

News

In-depth

You may also like